Bamifylline: Difference between revisions
No edit summary |
m Protected "Bamifylline": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
|
Latest revision as of 17:54, 18 August 2015
WikiDoc Resources for Bamifylline |
Articles |
---|
Most recent articles on Bamifylline Most cited articles on Bamifylline |
Media |
Powerpoint slides on Bamifylline |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Bamifylline at Clinical Trials.gov Clinical Trials on Bamifylline at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Bamifylline
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Bamifylline Discussion groups on Bamifylline Patient Handouts on Bamifylline Directions to Hospitals Treating Bamifylline Risk calculators and risk factors for Bamifylline
|
Healthcare Provider Resources |
Causes & Risk Factors for Bamifylline |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bamifylline is a drug of the xanthine chemical class which acts as a selective Adenosine receptor A1